Monthly Archives: August 2018

FDA Approves First Targeted Treatment of Polyneuropathy in Rare Disease – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Approves First Targeted Treatment of Polyneuropathy in Rare Disease – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA have approved the first targeted treatment for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Doctors Prescribe Fewer Opioids After Learning of Patient Overdoses – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Doctors Prescribe Fewer Opioids After Learning of Patient Overdoses – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 As health care providers work to combat the growing opioid … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

First Preventative Antimalarial In Almost 2 Decades Gets FDA Approval – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF First Preventative Antimalarial In Almost 2 Decades Gets FDA Approval – APhA submits compounding comments to FDA. – (866) 348-2889. The US Food and Drug Administration (FDA) has approved tafenoquine (Arakoda) … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Pharmacy Times and and Parata Systems Announce the 2018 Next-Generation Pharmacist Finalists – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Pharmacy Times and and Parata Systems Announce the 2018 Next-Generation Pharmacist Finalists – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Pharmacy Times® and Parata Systems, founding partners … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

US Drugs Not Consistently Aligned with Net Health Benefits – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF US Drugs Not Consistently Aligned with Net Health Benefits – APhA submits compounding comments to FDA. – (866) 348-2889. Unlike many other countries, health care reimbursements for medications in the United … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Okays Treatment for 2 Types of Non-Hodgkin Lymphoma – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Okays Treatment for 2 Types of Non-Hodgkin Lymphoma – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Officials with the FDA have approved a new treatment for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Expands Valsartan Products Recall – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Expands Valsartan Products Recall – APhA submits compounding comments to FDA. – (866) 348-2889. The FDA has expanded its recall of products containing valsartan, which is used in medications to … Continue reading

Posted in Pharmacist | Comments Off

Opioid Use: Non-opioid Tablet for Withdrawal Symptoms Available as FDA Encourages Treatment Medication Development – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Opioid Use: Non-opioid Tablet for Withdrawal Symptoms Available as FDA Encourages Treatment Medication Development – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 The FDA is encouraging … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

CDC: Put Vaccinations on Back-to-School Checklists – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF CDC: Put Vaccinations on Back-to-School Checklists – APhA submits compounding comments to FDA. – (866) 348-2889. August brings the end of summer vacation for children, and back-to-school checklists for parents. … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

New Data Support Move to Single-Tablet Darunavir-Based Regimen for Treating HIV – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Data Support Move to Single-Tablet Darunavir-Based Regimen for Treating HIV – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 New research demonstrates continued virologic control in patients … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off